A randomised controlled trial in diabetes demonstrating the positive impact of a patient activation strategy on diabetes processes and HbA1c: The WICKED project
dc.contributor.author | Gillani, Syed M R | |
dc.contributor.author | Nevill, Alan M. | |
dc.contributor.author | Singh, Baldev M | |
dc.date.accessioned | 2017-09-18T15:34:07Z | |
dc.date.available | 2017-09-18T15:34:07Z | |
dc.date.issued | 2017-06-25 | |
dc.identifier.citation | Gillani, SMR., Nevill, AM., Singh, BM. (2017) 'A randomised controlled trial in diabetes demonstrating the positive impact of a patient activation strategy on diabetes processes and HbA1c: The WICKED project', British Journal of Diabetes, 17 (2) pp. 58-63 | |
dc.identifier.issn | 1474-6514 | |
dc.identifier.doi | 10.15277/bjd.2017.134 | |
dc.identifier.uri | http://hdl.handle.net/2436/620663 | |
dc.description.abstract | Background: Patient activation is a demonstration of people participating effectively in their own care as measurable in objective outcomes. Techniques of activating patients are various. Aims: We developed a structured information booklet to promote patient activation and report the 1-year outcomes of a randomised controlled trial assessing its impact on diabetes care processes and on glycaemic control. Design and setting: It is an open label cluster randomised trial involving all people with diabetes aged more than 18 years within Wolverhampton Clinical Commissioning Group. Methods: All people with diabetes were cluster randomised into a group who were multiply mailed (MM) at 0, 3 and 6 months whilst a control group was mailed once at 3 months. Comparison of a Failed Process Score (FPS) between active and control groups was performed at 0, 3 and 12 months and of HbA1c at baseline and 12 months. Results: FPS improved significantly with multiple mailing (p=0.013), with particular impact on those with poor baseline FPS (≥2) (achieved FPS ≤1 at 12 months 49.2% vs. 46.0%, χ2=6.09, p<0.05). Overall HbA1c% across the year (adjusted) was significantly better with MM (p=0.021), with specific impact in those with a baseline HbA1c ≤7.5 (MM HbA1c% 6.7±0.07 (mean±SEM) vs. 7.0±0.09; mean±SEM difference 0.3±0.1, F=11.1, p=0.009). Conclusion: The direct provision of structured information to people with diabetes activates them to engage in their care delivery as reflected in care process and glycaemic control outcomes. | |
dc.language.iso | en | |
dc.publisher | ABCD (Diabetes Care) Ltd | |
dc.relation.url | http://www.bjd-abcd.com/index.php/bjd/article/view/224 | |
dc.subject | diabetes | |
dc.subject | care delivery | |
dc.subject | patient activation | |
dc.subject | patient engagement | |
dc.subject | key care processes | |
dc.title | A randomised controlled trial in diabetes demonstrating the positive impact of a patient activation strategy on diabetes processes and HbA1c: The WICKED project | |
dc.type | Journal article | |
dc.identifier.journal | British Journal of Diabetes | |
dc.date.accepted | 2017 | |
rioxxterms.funder | Jisc | |
rioxxterms.identifier.project | UOW181917AN | |
rioxxterms.version | AM | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
rioxxterms.licenseref.startdate | 2017-09-18 | |
dc.source.volume | 17 | |
dc.source.issue | 2 | |
dc.source.beginpage | 58 | |
dc.source.endpage | 63 | |
refterms.dateFCD | 2018-10-19T08:39:18Z | |
refterms.versionFCD | AM | |
refterms.dateFOA | 2017-09-18T00:00:00Z | |
html.description.abstract | Background: Patient activation is a demonstration of people participating effectively in their own care as measurable in objective outcomes. Techniques of activating patients are various. Aims: We developed a structured information booklet to promote patient activation and report the 1-year outcomes of a randomised controlled trial assessing its impact on diabetes care processes and on glycaemic control. Design and setting: It is an open label cluster randomised trial involving all people with diabetes aged more than 18 years within Wolverhampton Clinical Commissioning Group. Methods: All people with diabetes were cluster randomised into a group who were multiply mailed (MM) at 0, 3 and 6 months whilst a control group was mailed once at 3 months. Comparison of a Failed Process Score (FPS) between active and control groups was performed at 0, 3 and 12 months and of HbA1c at baseline and 12 months. Results: FPS improved significantly with multiple mailing (p=0.013), with particular impact on those with poor baseline FPS (≥2) (achieved FPS ≤1 at 12 months 49.2% vs. 46.0%, χ2=6.09, p<0.05). Overall HbA1c% across the year (adjusted) was significantly better with MM (p=0.021), with specific impact in those with a baseline HbA1c ≤7.5 (MM HbA1c% 6.7±0.07 (mean±SEM) vs. 7.0±0.09; mean±SEM difference 0.3±0.1, F=11.1, p=0.009). Conclusion: The direct provision of structured information to people with diabetes activates them to engage in their care delivery as reflected in care process and glycaemic control outcomes. |